Novel CRISPR/Cas9-based assay for studying DNA repair associated mutations
dc.contributor.advisor
Batada, Nizar
dc.contributor.advisor
Wood, Andrew
dc.contributor.author
Sakya, Siri Aastedatter
dc.date.accessioned
2022-11-15T10:14:59Z
dc.date.available
2022-11-15T10:14:59Z
dc.date.issued
2019-07-06
dc.description.abstract
DNA double-strand breaks (DSBs) are a lethal type of DNA damage and are primarily repaired by two main pathways: homologous recombination (HR) and classical non-homologous end joining (C-NHEJ). Impairment of HR or C-NHEJ leads to DSB repair through a less characterised pathway termed alternative non-homologous end joining (Alt-EJ). Recent studies suggest that Alt-EJ contributes to the formation of insertions/deletions and chromosomal translocations, which may cause cancer onset and progression. However, there is currently no existing Alt-EJ assay in the native chromatin context, and thus the underlying mechanism of the Alt-EJ pathway remains poorly understood.
In this Master project, I aimed to develop and implement a novel Alt-EJ assay termed Quantitative Multiplex Analysis of Translocations (QMAT-seq) that can quantify the frequency of translocation events and identify mutational signatures at the repair junctions of translocations. The assay exploits the RNA-guided CRISPR/Cas9 system to generate multiple DSBs in the genome, and the repair of these breaks by Alt-EJ leads to translocations. In this study, five guide-RNA (gRNA) sequences were selected, allowing for assessment of outcomes at 20 distinct translocation junctions. CRISPR/Cas9-mediated DSB formation was verified by the Surveyor nuclease assay and the translocation junctions were captured by nested PCR. Sanger sequencing of the translocation amplicons revealed that translocations form as expected, thus strongly supporting the feasibility of QMAT-seq.
However, QMAT-seq is still in its preliminary stage, and future perspectives include quantification of translocation frequencies, high-throughput sequencing, and an extensive bioinformatical analysis of mutational patterns at the translocation junctions. Moreover, the sensitivity of the assay needs to be quantified by perturbing known Alt-EJ factors and assessing if the resulting changes in translocation frequency and mutational patterns are consistent with what is known in the literature.
Upon completion, QMAT-seq will provide a means of identifying novel Alt-EJ factors, subtypes of Alt-EJ, and their underlying mechanism. Furthermore, characterisation of the Alt- EJ mutational signature can serve as a biomarker for deficiency in HR and C-NHEJ, which can aid in developing personalised cancer therapies. QMAT-seq thus promises to make a substantial contribution to the field of DNA repair and cancer biology.
en
dc.identifier.uri
https://hdl.handle.net/1842/39473
dc.identifier.uri
http://dx.doi.org/10.7488/era/2723
dc.language.iso
en
en
dc.publisher
The University of Edinburgh
en
dc.subject
DNA double-strand breaks
en
dc.subject
CRISPR/Cas9 technology
en
dc.subject
CRISPR/Cas9 vector construction
en
dc.subject
Lentiviral infection
en
dc.subject
nested PCR
en
dc.subject
QMAT-seq
en
dc.title
Novel CRISPR/Cas9-based assay for studying DNA repair associated mutations
en
dc.title.alternative
A novel CRISPR/Cas9-based assay for studying DNA repair associated mutations
en
dc.type
Thesis or Dissertation
en
dc.type.qualificationlevel
Masters
en
dc.type.qualificationname
MSc(R) Master of Science by Research
en
Files
Original bundle
1 - 1 of 1
- Name:
- SakyaSA_2019.pdf
- Size:
- 5.51 MB
- Format:
- Adobe Portable Document Format
- Description:
This item appears in the following Collection(s)

